24 HOUR WU ALLOCATION
| Research | Percent |
|---|---|
|
IL 2 FORCE FIELD BENCHMARKING |
100% |
7 DAY WU ALLOCATION
| Research | Percent |
|---|---|
|
ANTIBODY DYNAMICS SIMULATION |
37.14% |
|
ANTIBODY AFFINITY MATURATION |
17.14% |
|
IL 2 DYNAMICS SIMULATIONS |
17.14% |
|
IL 2 FORCE FIELD BENCHMARKING |
11.43% |
|
ANTIBODY DYNAMICS |
11.43% |
|
ENZYME DYNAMICS |
5.71% |
12 WEEK WU ALLOCATION
| Research | Percent |
|---|---|
|
ANTIBODY DYNAMICS SIMULATION |
30.18% |
|
CANCER |
23.02% |
|
ANTIBODY AFFINITY MATURATION |
14.83% |
|
ENZYME DYNAMICS |
11.51% |
|
IL 2 FORCE FIELD BENCHMARKING |
8.18% |
|
IL 2 DYNAMICS SIMULATIONS |
7.42% |
|
ANTIBODY DYNAMICS |
3.07% |
|
IL2 RECEPTOR DYNAMICS |
1.79% |